-transparent.png){kind=logo}
Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains. 2010
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
A series of 27 salicylanilide-based carbamates was prepared as a part of our ongoing search for new antituberculosis drugs. These compounds exhibited very good in vitro activity against Mycobacterium tuberculosis, Mycobacterium kansasii and Mycobacterium avium and, in particular, against five multidrug-resistant strains, with MIC values between 0.5-2 micromol/L. Moreover, they displayed moderate toxicity against intestinal cells with the selectivity index being up to 96. Furthermore, acid stability and a half-life of 43h at pH 7.4 were shown. Thus, these novel salicylanilide derivatives are drug candidates which should be seriously consider for further screening.
Related Publications
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
September 2007,
Bioorganic & medicinal chemistry letters,
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
March 2014,
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
October 2012,
Molecules (Basel, Switzerland),
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
April 2005,
Bioorganic & medicinal chemistry letters,
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
August 2015,
European journal of medicinal chemistry,
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
April 2021,
ChemMedChem,
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
July 2013,
Tuberculosis (Edinburgh, Scotland),
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
December 2006,
International journal of antimicrobial agents,
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
January 2013,
The Journal of antibiotics,
Juana M Férriz, and
Katerina Vávrová, and
Filip Kunc, and
Ales Imramovský, and
Jirina Stolaríková, and
Eva Vavríková, and
Jarmila Vinsová
August 2012,
Antimicrobial agents and chemotherapy,
